>>8921864 lb
Aytu BioScience Signs Exclusive Global License with Cedars-Sinai for Potential Coronavirus Treatment'
ENGLEWOOD, CO / ACCESSWIRE / April 20, 2020 / Aytu BioScience, Inc. (NASDAQ: AYTU) (the “Company”), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today that it has signed an exclusive worldwide license from Cedars-Sinai to develop and commercialize the Healight Platform Technology (“Healight”). This medical device technology platform, discovered and developed by scientists at Cedars-Sinai, is being studied as a potential first-in-class treatment for coronavirus and other respiratory infections.
https://www.sec.gov/Archives/edgar/data/1385818/000165495420004215/aytu_ex991.htm